Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices

By Contrera J.F.   Matthews E.J.   Daniel Benz R.  

Regulatory Toxicology and Pharmacology, Vol. 38, Iss. 3, 2003-12 ,pp. : 243-259

Elsevier

Access to resources Recommend Favorite

Evaluation of the Carcinogenic Potential of Pharmaceuticals: Opportunities Arising from the International Conference on Harmonisation

By Monro A.M.  

Drug Safety, Vol. 18, Iss. 5, 1998-05 ,pp. : 309-319

Adis International

Access to resources Recommend Favorite

QSAR Modeling of Carcinogenic Risk Using Discriminant Analysis and Topological Molecular Descriptors

By  

Current Drug Discovery Technologies, Vol. 2, Iss. 2, 2005-06 ,pp. : 55-67

Bentham Science Publishers

Access to resources Recommend Favorite

Assessing the Potential Toxicity of New Pharmaceuticals

By  

Current Topics in Medicinal Chemistry, Vol. 1, Iss. 4, 2001-09 ,pp. : 233-245

Bentham Science Publishers

Access to resources Recommend Favorite

Noninvasive Visualization of Pharmacokinetics, Biodistribution and Tumor Targeting of Poly[N-(2-hydroxypropyl)methacrylamide] in Mice Using Contrast Enhanced MRI

By Wang Yanli   Ye Furong   Jeong Eun-Kee   Sun Yongen   Parker Dennis   Lu Zheng-Rong  

Pharmaceutical Research, Vol. 24, Iss. 6, 2007-06 ,pp. : 1208-1216

Springer Publishing Company

Access to resources Recommend Favorite